Status:
COMPLETED
Cognitive-behavioural Intervention for Anxiety, Depression and Quality of Life Among Children Receiving Chemotherapy.
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Hematologic Malignancy
Anxiety
Eligibility:
All Genders
8-18 years
Phase:
NA
Brief Summary
The diagnosis and treatment of paediatric cancer is the most stressful experience for children and their families. Nearly all paediatric cancer patients are presented with at least one psychosocial pr...
Detailed Description
The application of cognitive-behavioural therapy (CBT) has been used for the management of anxiety and depression. Nowadays, evidence suggests that CBT has promising effects on improving psychological...
Eligibility Criteria
Inclusion
- 8 to 18-year-old children
- Diagnosed with haematological cancer
- Receiving chemotherapy
- Able to communicate (speak, read and write) with the local language, Amharic
- Able to provide written parental consent and oral child assent
Exclusion
- Have a history of developmental problems, psychological or psychiatric illness
- Unable to collaborate in the study due to acute illness
- Have hearing or speech problems
Key Trial Info
Start Date :
April 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 20 2022
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT05270655
Start Date
April 12 2022
End Date
October 20 2022
Last Update
February 8 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Tikur Anbesa specialised hospital
Addis Ababa, Ethiopia
2
University of Gondar specialised hospital
Gonder, Ethiopia